SMTI (Sanara MedTech Inc. Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by SMTI officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-05 | Eric D Major | Director | A | — | — |
| 2026-06-05 | ERIC D TANZBERGER | Director | A | — | — |
| 2026-06-05 | Robert Andrew DeSutter | Director | A | — | — |
| 2026-06-05 | Ann Beal Salamone | Director | A | — | — |
| 2026-06-05 | Keith G Myers | Director | A | — | — |
| 2026-06-05 | Ronald T Nixon | Director | A | — | — |
| 2026-06-05 | Sara N Ortwein | Director | A | — | — |
| 2026-06-05 | Roszell III Mack | Director | A | — | — |
| 2026-05-18 | Seth D Yon | Chief Executive Officer | F | — | — |
| 2026-05-05 | Ashley M Mackey | Controller | A | — | — |
| 2026-04-16 | Jacob A. Waldrop | Chief Operating Officer | F | — | — |
| 2026-03-23 | Ashley M Mackey | Controller | A | — | — |
| 2026-03-23 | Jacob A. Waldrop | Chief Operating Officer | A | — | — |
| 2026-03-23 | Seth D Yon | Chief Executive Officer | A | — | — |
| 2026-03-23 | Elizabeth B Taylor | Chief Financial Officer | A | — | — |
| 2026-03-10 | Seth D Yon | Chief Executive Officer | F | — | — |
| 2026-03-09 | Seth D Yon | Chief Executive Officer | F | — | — |
| 2026-03-02 | Seth D Yon | Chief Executive Officer | F | — | — |
| 2026-02-27 | Elizabeth B Taylor | Chief Financial Officer | F | — | — |
| 2026-02-27 | Seth D Yon | Chief Executive Officer | F | — | — |
| 2026-02-27 | Ashley M Mackey | Controller | F | — | — |
| 2026-02-27 | Jacob A. Waldrop | Chief Operating Officer | F | — | — |
| 2025-09-16 | Seth D Yon | Chief Executive Officer | A | — | — |
| 2025-08-19 | Michael D. McNeil | Ch. Acct. & Ch. Admin. Officer | F | — | — |
| 2025-05-28 | ERIC D TANZBERGER | Director | A | — | — |
| 2025-05-27 | Keith G Myers | Director | A | — | — |
| 2025-05-27 | Ann Beal Salamone | Director | A | — | — |
| 2025-05-27 | Sara N Ortwein | Director | A | — | — |
| 2025-05-27 | Roszell III Mack | Director | A | — | — |
| 2025-05-27 | Robert Andrew DeSutter | Director | A | — | — |
| 2025-05-27 | Eric D Major | Director | A | — | — |
| 2025-05-16 | Seth D Yon | Pres. & Ch. Commercial Officer | F | — | — |
| 2025-04-17 | Jacob A. Waldrop | Chief Operating Officer | F | — | — |
| 2025-04-11 | Michael D. McNeil | Ch. Acct. & Ch. Admin. Officer | F | — | — |
| 2025-03-21 | Michael D. McNeil | Ch. Acct. & Ch. Admin. Officer | A | — | — |
| 2025-02-27 | Michael D. McNeil | Ch. Acct. & Ch. Admin Officer | A | — | — |
| 2025-02-27 | Elizabeth B Taylor | Chief Financial Officer | A | — | — |
| 2025-02-27 | Jacob A. Waldrop | Chief Operating Officer | A | — | — |
| 2025-02-27 | Ronald T Nixon | Chief Executive Officer | A | — | — |
| 2024-11-13 | Keith G Myers | Director | A | — | — |
| 2024-06-14 | Sara N Ortwein | Director | A | — | — |
| 2024-06-14 | Robert Andrew DeSutter | Director | A | — | — |
| 2024-06-14 | Eric D Major | Director | A | — | — |
| 2024-06-14 | ERIC D TANZBERGER | Director | A | — | — |
| 2024-06-14 | Ann Beal Salamone | Director | A | — | — |
| 2024-06-14 | Roszell III Mack | Director | A | — | — |
| 2024-06-14 | Ronald T Nixon | Chief Executive Officer | A | — | — |
| 2024-06-14 | JAMES W STUCKERT | Director | A | — | — |
| 2024-04-16 | Jacob A. Waldrop | Chief Operating Officer | A | — | — |
| 2024-03-11 | Michael D. McNeil | Chief Financial Officer | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Chief Executive Officer | 1,032,052 | — |
| — | Director | 850,218 | — |
| — | Chief Executive Officer | 109,546 | — |
| — | Chief Executive Officer | 48,854 | — |
| — | Director | 28,740 | — |
| — | Ch. Acct. & Ch. Admin. Officer | 28,587 | — |
| — | President - Telehealth Svcs. | 28,032 | — |
| — | Director | 26,858 | — |
| — | Director | 25,415 | — |
| — | Chief Operating Officer | 24,377 | — |
| — | Director | 22,966 | — |
| — | Principal Executive Officer | 22,113 | — |
| — | Director | 21,842 | — |
| — | Chief Financial Officer | 17,632 | — |
| — | Director | 16,945 | — |
| — | Director | 14,232 | — |
| — | Pres. - Strategic Partnerships | 11,469 | — |
| — | President - R&D | 9,595 | — |
| — | Director | 9,325 | — |
| — | Controller | 4,967 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the SMTI quote page; the site-wide leaderboard is on the insider transactions hub.